Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer
Clinical trial NCT04348032 · UNKNOWN
Trial details
- NCT number
- NCT04348032
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-22
- Primary completion
- 2021-01-28
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.